Gene-Disorder Association · Article
First reported
1950
Supporting publications
28
Approved treatment annotated
Association Review
In brief
The association between CCND1 (Cyclin D1) and Squamous Cell Carcinoma, Head And Neck is reported, supported by a single source.
Sources
1
Clinical variants
0
Symptoms
9
Compounds
3
Trials
187of 2,479 via CCND1 compounds
Publications
28
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
04
Squamous Cell Carcinoma, Head And Neck
The disorder
32 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
05
Phenotype
Clinical features
1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
06
Interventions
Therapeutics
3 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
07
Human studies
Clinical trials
2,479 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
28 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
09
Provenance
References & sources
16 references
Every source and publication cited across this dossier, as one numbered reference list.
